Preferred Label : zotarolimus;

MeSH note : synthetic analog of rapamycin; structure in first source;

CISMeF synonym : ABT-578;

MeSH synonym : zotarilumus;

MeSH hyponym : ABT 578; ABT578;

Is substance : O;

UNII : H4GXR80IZE;

InChIKey : CGTADGCBEXYWNE-JUKNQOCSSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3523611/fr/resolute-onyx
2024
France
health technology assessment
Endoprosthesis
Cover
Zotarolimus
Coronary Artery Stent
zotarolimus
Active Control
Active License
Coat
Stent
stents
pharmacologist
Ethylene-vinyl Alcohol Copolymer-based Embolic Agent
Joy
pharmacology
Product Part
Active State
Pharmacology
zotarolimus
Stenting
Pet is as Active as it Has Been

---
https://www.has-sante.fr/jcms/p_3512096/fr/resolute-integrity
2024
France
health technology assessment
Pet is as Active as it Has Been
Active State
Coronary Artery Stent
Pharmacology
Zotarolimus
Active Control
Joy
pharmacologist
pharmacology
Coat
Endoprosthesis
Stenting
zotarolimus
Cover
Active License
stents
Stent
zotarolimus
Product Part

---
https://www.has-sante.fr/jcms/p_3408180/fr/endeavor-resolute
2023
France
health technology assessment
zotarolimus
Endoprosthesis
zotarolimus
pharmacology
stents
pharmacologist

---
https://www.has-sante.fr/jcms/p_3372071/fr/onyx-frontier
2022
France
health technology assessment
pharmacology
pharmacologist
zotarolimus
stents
zotarolimus

---
https://www.has-sante.fr/portail/jcms/c_2912811/fr/resolute-integrity
2019
false
true
false
false
France
coronary disease
treatment outcome
stents
coronary disease
health technology assessment
zotarolimus
stents
sirolimus

---
https://www.has-sante.fr/portail/jcms/c_2865967/fr/resolute-onyx
2018
false
false
false
France
French
health technology assessment
stents
pharmacology
pharmacologic
active
pharmacologist
zotarolimus
sirolimus

---
http://www.has-sante.fr/portail/jcms/c_1622853/fr/resolute-integrity
http://www.has-sante.fr/portail/jcms/c_1622852/fr/resolute-integrity
2013
France
French
CORONARY STENT, OTHER
health technology assessment
Drug-Eluting stents
sirolimus
zotarolimus
coronary artery disease
treatment outcome

---
http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000025388591&dateTexte=&categorieLien=id
2012
France
legislation
zotarolimus
sleep apnea syndromes
stents
societies
equipment safety
social security
traction
france
aortic stenosis, subvalvular
zotarolimus

---
http://www.has-sante.fr/portail/jcms/c_1351909/resolute-integrity
2012
France
French
CORONARY STENT, OTHER
coronary artery disease
Drug-Eluting stents
zotarolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1068127/resolute-integrity-12-juillet-2011-3835-avis
http://www.has-sante.fr/portail/jcms/c_1079790/resolute-integrity-12-juillet-2011-3835-avis
2011
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
sirolimus
zotarolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1197007/endeavor-resolute-3834-et-resolute-integrity-3835-12-juillet-2011-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1216278/endeavor-resolute-3834-resolute-integrity-3835-12-juillet-2011-synthese-d-avis
2011
France
French
ACTIVE CORONARY STENT
sirolimus
Drug-Eluting stents
zotarolimus
sirolimus
coronary artery disease
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1067927/endeavor-resolute-12-juillet-2011-3834-avis
http://www.has-sante.fr/portail/jcms/c_1079788/endeavor-resolute-12-juillet-2011-3834-avis
2011
France
French
ACTIVE CORONARY STENT
diagnostic uses of chemicals
Drug-Eluting stents
zotarolimus
sirolimus
coronary artery disease
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1011979/resolute-integrity-21-decembre-2010-3352-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
coronary artery disease
zotarolimus
sirolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_994680/endeavor-resolute-12-octobre-2010-2806-avis
http://www.has-sante.fr/portail/jcms/c_994684/endeavor-resolute-12-octobre-2010-2806-avis
2010
France
French
ACTIVE CORONARY STENT
coronary artery disease
Drug-Eluting stents
zotarolimus
sirolimus
sirolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_1001613/endeavor-et-endeavor-sprint-rx-04-mai-2010-2373-2377-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1016552/endeavor-endeavor-sprint-04-mai-2010-2373-2377-synthese-d-avis
2010
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
zotarolimus
sirolimus
sirolimus
health technology assessment
guidelines for medical devices use
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_716885/endeavor
http://www.has-sante.fr/portail/jcms/c_716886/endeavor-cepp-1879
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
sirolimus
coronary artery disease
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/jcms/c_671429/endeavor
http://www.has-sante.fr/portail/jcms/c_671462/cepp-1744
2008
France
French
ACTIVE CORONARY STENT
Drug-Eluting stents
sirolimus
angioplasty, balloon, coronary
coronary restenosis
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_522790
2007
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_616564
http://www.has-sante.fr/portail/display.jsp?id=c_616565
2007
France
French
ACTIVE CORONARY STENT
coronary artery disease
sirolimus
zotarolimus
health technology assessment
treatment outcome

---
http://www.has-sante.fr/portail/display.jsp?id=c_398739
2006
France
French
ACTIVE CORONARY STENT
diabetes mellitus
sirolimus
Drug-Eluting stents
coronary stenosis
zotarolimus
health technology assessment
treatment outcome

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.